可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Stein S,Lohmann C,Sch?fer N,et al.SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis[J].Eur Heart J,2010,31(18):2301-2309.
[2]Libby P,Okamoto Y,Rocha VZ,et al.Inflammation in Atherosclerosis:Transition From Theory to Practice[J].Circ J,2010,74(2):213-220.
[3]Wang L,Peng Q,Wang H,et al.NLRP3 inflammasome a novel link between lipoproteins and atherosclerosis[J].Arch Med Sci,2016,12(5):950-958.
[4]Duewell P,Kono H,Rayner KJ,et al.NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals[J].Nature,2010,464(7293):1357-1361.
[5]Wang L,Qu P,Zhao J,et al.NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease[J].Arch Med Sci,2014,10(4):791-800.
[6]Menu P,Pellegrin M,Aubert JF,et al.Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome[J].Cell Death and Disease,2011,2(3):e137.
[7]da Motta NA,Kummerle AE,Marostica E,et al.Anti-atherogenic Effects of a New Thienylacylhydrazone Derivative,LASSBio-788,in Rats Fed a Hypercholesterolemic Diet[J].J Pharmacol Sci,2013,123(1):47-57.
[8]王园园,龙民慧,邹民吉,等.大鼠动脉粥样硬化动物模型的建立和评价[J]. 中国实验动物学报, 2008, 16(6):421-423.
[9]Lee HM, Kim JJ, Kim HJ, et al. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes[J].Diabetes,2013,62(1):194-204.
[10]Mao Z,Liu C,Ji S,et al.The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats[J].Neurochem Res,2017,42(4):1104-1115.
[11]Tran H,Jacqueline T,Hira S,et al.Role of interleukin-1 inhibitors in the management of gout[J].Pharmacotherapy,2013,33(7):744-53.
[12]Lin J,Shou X,Mao X,et al.Oxidized low density lipoprotein induced caspase-1 mediated pyroptotic cell death in macrophages:implication in lesion instability?[J].PLoS ONE,2013,8(4):e62148.
[13]Jiang Y,Wang M,Huang K,et al.Oxidized low-density lipoprotein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation[J].Biochem Biophys Res Commun,2012,425(2):121-126.
[14]Liu W,Yin Y,Zhou Z,et al.OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation[J].Inflamm Res,2014,63(1):33-43.
[15]Martinon F,Pétrilli V,Mayor A,et al.Gout-associated uric acid crystals activate the NALP3 inflammasom[J].Natrue,2006,440(7081):237-241.
[16]Carta S,Tassi S,Semino C,et al.Histone deacetylase inhibitors prevent exocytosis of interleukin-1 containing secretory lysosomes:role of microtubules[J].Blood,2006,10(8):1618-1626.
[17]Franz-Wachtel M,Eisler SA,Krug K,et al.Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells[J].Mol Cell Proteomics,2012,11(5):160-170.
[18]Misawa T,Takahama M,Kozaki T,et al.Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome[J].Nat Immunol,2013,14(5):454-460.